)
Business philosophy21 May 2026
Target's New CEO: Michael Fiddelke
After more than 20 years at Target, Michael Fiddelke now carries the responsibility of reviving the retailer's growth.
InMed Pharmaceuticals
InMed Pharmaceuticals (INM) investor relations material
InMed Pharmaceuticals M&A announcement summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.M&A announcement summary19 May, 2026
Deal rationale and strategic fit
Merger combines differentiated migraine prevention pipeline with public market infrastructure to accelerate therapy development for over 1 billion migraine sufferers globally.
Lead programs target complementary pathways, aiming to address unmet needs in patients unresponsive to current anti-CGRP therapies.
Pipeline designed for superior convenience and efficacy, leveraging subcutaneous delivery and dual pathway inhibition.
Financial terms and conditions
All-stock transaction with pre-merger shareholders expected to own 1.51% of the combined company, which will have a pro forma equity value of approximately $421.4 million.
InMed shareholders eligible for additional consideration via potential dividends or contingent value rights tied to monetization of legacy assets and excess closing net cash.
Synergies and expected cost savings
Combined entity expected to expedite development timelines and leverage capital to fund operations through 2028, supporting key clinical milestones.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from InMed Pharmaceuticals
- Q3 2026 net loss rose to $3.0M as R&D costs increased and commercial operations wind-down began.INM
Q3 20267 May 2026 - Plans to raise up to $50M via flexible securities offerings amid ongoing financial challenges.INMRegistration filing20 Mar 2026
- Lead Alzheimer's candidate shows robust preclinical results; clinical trials targeted for 2027.INMSidoti March Small-Cap Virtual Conference18 Mar 2026
- Revenue dropped 26% as INM-901 advanced, with cash reserves and regulatory risks in focus.INMQ2 202612 Feb 2026
- Promising preclinical data in Alzheimer's and dry AMD, with strong financial and commercial support.INMEmerging Growth Conference 723 Feb 2026
- INM-901 and precision medicine are driving advances in Alzheimer's therapy and research.INMStatus Update14 Jan 2026
- INM-901 shows strong preclinical promise for Alzheimer's, with commercial revenue supporting R&D.INMH.C. Wainwright 27th Annual Global Investment Conference31 Dec 2025
- Promising preclinical results in Alzheimer's and dry AMD drive focus on partnerships and 2026 milestones.INMLife Sciences Virtual Investor Forum 202512 Dec 2025
- Shareholders will vote on director elections, auditor re-appointment, and a major share issuance.INMProxy Filing1 Dec 2025
Next InMed Pharmaceuticals earnings date
Q4 202623 Sep, 2026
InMed Pharmaceuticals
Next InMed Pharmaceuticals earnings date
Q4 202623 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy20 May 2026
McDonald's CEO: Chris Kempczinski
Chris Kempczinski rose from consumer brands to McDonald's CEO, leading the company through disruption and renewed growth.
)
Business philosophy20 May 2026
Apple's Next CEO: John Ternus
From engineer to CEO, John Ternus spent 25 years building Apple's biggest products and now begins its next chapter.
Frequently asked questions
Explore our global coverage